Literature DB >> 19894024

Genistein, a potent inhibitor of secretory phospholipase A2: a new insight in down regulation of inflammation.

Kattepura K Dharmappa1, Riyaz Mohamed, Holenarasipura V Shivaprasad, Bannikuppe Sannanaik Vishwanath.   

Abstract

OBJECTIVES: Some of the legumes, spices and medicinal herbs rich in genistein are known for their anti-inflammatory properties. Anti-inflammatory property of these herbs is determined by subjecting secretory phospholipase A(2) (sPLA(2)) inhibition, a key enzyme in the inflammatory reactions by genistein.
MATERIALS AND METHODS: Genistein was assessed for inhibition of sPLA(2) activity using (14)C-oleate radiolabelled Escherichia coli membrane as substrate. The enzyme-inhibitor interaction was established by intrinsic fluorescence and circular dichroism studies. The in vivo anti-inflammatory activity was tested by injecting sPLA(2), Vipera russelli venom phospholipase-V (VRV-PL-V) with different concentrations of genistein in the range of 3-21 muM into intra plantar surface of right hind footpad of mice. Systemic effect was tested by administering the genistein (21 muM) i.p. 30 min before and immediately after sPLA(2) injection. RESULT: Genistein inhibited sPLA(2) enzymes of inflammatory exudates (human synovial fluid and human pleural fluid) and snake venoms (VRV-PL-V and Naja naja phospholipase-I) in a concentration dependent manner with IC(50) values ranging from 5.75 to 11.75 muM. Increasing the calcium (Ca(2+)) concentration from 2.5 to 15 mM and substrate concentration up to 120 nM did not alter the level of inhibition. Genistein alters the intrinsic fluorescence intensity and shown apparent shift in far ultra violet-circular dichroism spectra of VRV-PL-V, indicating the direct interaction with enzyme. Genistein also inhibited the VRV-PL-V induced mouse paw oedema in a concentration dependent manner. The genistein at 21 muM concentration administered immediately after the VRV-PL-V injection, effectively neutralized the oedema inducing activity.
CONCLUSION: Genistein inhibited sPLA(2) activity of both inflammatory exudates and snake venoms in a concentration dependent manner and sPLA(2) induced mouse paw oedema. The study partially explains the observed anti-inflammatory property of several medicinal herbs which containing genistein.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19894024     DOI: 10.1007/s10787-009-0018-8

Source DB:  PubMed          Journal:  Inflammopharmacology        ISSN: 0925-4692            Impact factor:   4.473


  31 in total

1.  Chromatography of rattlesnake venom; a separation of three phosphodiesterases.

Authors:  H G BOMAN; U KALETTA
Journal:  Biochim Biophys Acta       Date:  1957-06

2.  Oral treatment with genistein reduces the expression of molecular and biochemical markers of inflammation in a rat model of chronic TNBS-induced colitis.

Authors:  Jan Seibel; Almut F Molzberger; Torsten Hertrampf; Ute Laudenbach-Leschowski; Patrick Diel
Journal:  Eur J Nutr       Date:  2009-02-21       Impact factor: 5.614

3.  Characterization of three edema-inducing phospholipase A2 enzymes from habu (Trimeresurus flavoviridis) venom and their interaction with the alkaloid aristolochic acid.

Authors:  B S Vishwanath; R M Kini; T V Gowda
Journal:  Toxicon       Date:  1987       Impact factor: 3.033

Review 4.  PLA2 mediated arachidonate free radicals: PLA2 inhibition and neutralization of free radicals by anti-oxidants--a new role as anti-inflammatory molecule.

Authors:  B L Nanda; A Nataraju; R Rajesh; K S Rangappa; M A Shekar; B S Vishwanath
Journal:  Curr Top Med Chem       Date:  2007       Impact factor: 3.295

5.  Anti-inflammatory activity of oleanolic acid by inhibition of secretory phospholipase A2.

Authors:  Kattepura K Dharmappa; Raju Venkatesh Kumar; Angaswamy Nataraju; Riyaz Mohamed; Holenarasipura V Shivaprasad; Bannikuppe S Vishwanath
Journal:  Planta Med       Date:  2008-12-11       Impact factor: 3.352

6.  First structural evidence of a specific inhibition of phospholipase A2 by alpha-tocopherol (vitamin E) and its implications in inflammation: crystal structure of the complex formed between phospholipase A2 and alpha-tocopherol at 1.8 A resolution.

Authors:  Vikas Chandra; Jayasankar Jasti; Punit Kaur; Ch Betzel; A Srinivasan; T P Singh
Journal:  J Mol Biol       Date:  2002-07-05       Impact factor: 5.469

7.  Inhibition of human non-pancreatic phospholipases A2 by retinoids and flavonoids. Mechanism of action.

Authors:  A A Fawzy; B S Vishwanath; R C Franson
Journal:  Agents Actions       Date:  1988-12

8.  Purification of a soluble phospholipase A2 from synovial fluid in rheumatoid arthritis.

Authors:  E Stefanski; W Pruzanski; B Sternby; P Vadas
Journal:  J Biochem       Date:  1986-11       Impact factor: 3.387

9.  Inhibition of phospholipase A2 by "lipocortins" and calpactins. An effect of binding to substrate phospholipids.

Authors:  F F Davidson; E A Dennis; M Powell; J R Glenney
Journal:  J Biol Chem       Date:  1987-02-05       Impact factor: 5.157

10.  Effects of organometals on cellular signaling. II. Inhibition of reincorporation of free arachidonic acid and influence on paf-acether synthesis by triethyllead.

Authors:  H F Krug; D Mattern; J Bidault; E Ninio
Journal:  Environ Health Perspect       Date:  1994-09       Impact factor: 9.031

View more
  14 in total

Review 1.  Vascular effects of phytoestrogens and alternative menopausal hormone therapy in cardiovascular disease.

Authors:  V B Gencel; M M Benjamin; S N Bahou; R A Khalil
Journal:  Mini Rev Med Chem       Date:  2012-02       Impact factor: 3.862

2.  Chemical modification of ascorbic acid and evaluation of its lipophilic derivatives as inhibitors of secretory phospholipase A(2) with anti-inflammatory activity.

Authors:  Riyaz Mohamed; K K Dharmappa; Shaista Tarannum; N M Jameel; S A Kannum; H S Ashrafulla; Lokanath Rai; Cletus Jmd' Souza; M A Shekhar; Bannikuppe S Vishwanath
Journal:  Mol Cell Biochem       Date:  2010-08-22       Impact factor: 3.396

Review 3.  Targeting NADPH oxidase and phospholipases A2 in Alzheimer's disease.

Authors:  Agnes Simonyi; Yan He; Wenwen Sheng; Albert Y Sun; W Gibson Wood; Gary A Weisman; Grace Y Sun
Journal:  Mol Neurobiol       Date:  2010-03-02       Impact factor: 5.590

4.  Modulation of lipopolysaccharide-induced pro-inflammatory mediators by an extract of Glycyrrhiza glabra and its phytoconstituents.

Authors:  P Thiyagarajan; C V Chandrasekaran; H B Deepak; Amit Agarwal
Journal:  Inflammopharmacology       Date:  2011-02-17       Impact factor: 4.473

Review 5.  Genistein: the potential for efficacy in rheumatoid arthritis.

Authors:  Jinchao Li; Dong Gang; Xiaowei Yu; Yiping Hu; Ye Yue; Wenxiang Cheng; Xiaohua Pan; Peng Zhang
Journal:  Clin Rheumatol       Date:  2013-01-10       Impact factor: 2.980

6.  Inhibition of Neurotoxic Secretory Phospholipases A(2) Enzymatic, Edematogenic, and Myotoxic Activities by Harpalycin 2, an Isoflavone Isolated from Harpalyce brasiliana Benth.

Authors:  Rafael M Ximenes; Marcelo M Rabello; Renata M Araújo; Edilberto R Silveira; Fábio H R Fagundes; Eduardo B S Diz-Filho; Simone C Buzzo; Veronica C G Soares; Daniela de O Toyama; Henrique H Gaeta; Marcelo Z Hernandes; Helena S A Monteiro; Marcos H Toyama
Journal:  Evid Based Complement Alternat Med       Date:  2012-07-31       Impact factor: 2.629

7.  Changes in the anti-inflammatory activity of soy isoflavonoid genistein versus genistein incorporated in two types of cyclodextrin derivatives.

Authors:  Corinatiulea Danciu; Codruta Soica; Erzsebet Csanyi; Rita Ambrus; Stefana Feflea; Camelia Peev; Cristina Dehelean
Journal:  Chem Cent J       Date:  2012-06-20       Impact factor: 4.215

8.  Formononetin inhibits lipopolysaccharide-induced release of high mobility group box 1 by upregulating SIRT1 in a PPARδ-dependent manner.

Authors:  Jung Seok Hwang; Eun Sil Kang; Sung Gu Han; Dae-Seog Lim; Kyung Shin Paek; Chi-Ho Lee; Han Geuk Seo
Journal:  PeerJ       Date:  2018-01-03       Impact factor: 2.984

9.  Anti-Atherosclerotic Effects of a Phytoestrogen-Rich Herbal Preparation in Postmenopausal Women.

Authors:  Veronika A Myasoedova; Tatyana V Kirichenko; Alexandra A Melnichenko; Varvara A Orekhova; Alessio Ravani; Paolo Poggio; Igor A Sobenin; Yuri V Bobryshev; Alexander N Orekhov
Journal:  Int J Mol Sci       Date:  2016-08-11       Impact factor: 5.923

Review 10.  Isoflavones: Anti-Inflammatory Benefit and Possible Caveats.

Authors:  Jie Yu; Xiaojuan Bi; Bing Yu; Daiwen Chen
Journal:  Nutrients       Date:  2016-06-10       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.